If the shy or the scatterbrained take cognitiveenhancers, it is not obvious whether this is levelling their playing field or giving them an unfair advantage.
Remember that the new drugs will have passed clinical trials because they are treatments for a disease, even if they have not been licensed as cognitiveenhancers.